Trueblue (TBI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 14, 2025, will be held virtually, with shareholders able to submit questions and vote online, by phone, or by mail.
Proxy materials and the 2024 Annual Report are available online, with a focus on resource conservation and cost reduction in delivery.
2024 business highlights include $1.6 billion in revenue, $11.2 million in adjusted EBITDA, and $21.1 million returned to shareholders via stock repurchases.
Operations were streamlined, including the divestiture of a non-core business and technology enhancements such as a new JobStack app launch.
Voting matters and shareholder proposals
Shareholders will vote on: election of nine directors (eight independent), advisory approval of executive compensation, approval of the amended 2016 Omnibus Incentive Plan, and ratification of Deloitte & Touche LLP as auditor.
Board recommends voting FOR all proposals; brokers cannot vote on director election, say-on-pay, or incentive plan without instructions.
Board of directors and corporate governance
Board consists of nine directors, eight of whom are independent; all directors are elected annually by majority vote.
Board Chair and CEO roles are separated; succession planning and annual evaluations are in place.
Four standing committees: Audit, Compensation, Governance, and Innovation & Technology, all with independent members except the I&T Committee.
Board and committees conduct annual self-evaluations and ongoing feedback to improve effectiveness.
Directors and executives are subject to meaningful stock ownership guidelines and anti-hedging policies.
Latest events from Trueblue
- Board refreshment and profitability initiatives advance as proxy contest with EHS continues.TBI
Proxy Filing3 Mar 2026 - Revenue up 8% to $418M, but net loss widened on impairment; margin pressure persists.TBI
Q4 202518 Feb 2026 - Q2 revenue down 17% to $396M, net loss $105M, with cost cuts and digital focus amid uncertainty.TBI
Q2 20242 Feb 2026 - Digital innovation and market expansion drive growth and margin gains in a fragmented staffing sector.TBI
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Q3 revenue dropped 19.2% with a $59.1M goodwill impairment and strong cost controls.TBI
Q3 202416 Jan 2026 - Board refreshment and strategic initiatives position the company for long-term growth.TBI
Proxy Filing9 Jan 2026 - Board refreshment and strategic focus highlighted as proxy process begins for 2026.TBI
Proxy Filing9 Jan 2026 - Q4 revenue fell 22% but margin gains, cost cuts, and healthcare expansion support recovery.TBI
Q4 202424 Dec 2025 - Board appointments and refreshment aim to drive growth, oversight, and long-term value.TBI
Proxy Filing2 Dec 2025